The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
ReShape Lifesciences® Enters Into Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys
Jul 09, 2024•almost 2 years ago
Contract Type
agreement
San ClementeHealthcare
Description
ReShape Lifesciences® has entered into a definitive merger agreement with Vyome Therapeutics, Inc., a clinical-stage company targeting immuno-inflammatory and rare diseases. Additionally, ReShape entered into an asset purchase agreement with Biorad Medisys, Pvt. Ltd.
Company Information
Company
ReShape
Location
1001 CALLE AMANECER
San Clemente, California, United States
About
ReShape is a company dedicated to transforming healthcare through innovative solutions. They focus on providing effective treatments and medical devices to improve patient outcomes. The merger with Vyome is set to bolster their capabilities and market reach. ReShape is committed to advancing healthcare solutions.
San ClementeHealthcare